• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊马替尼通过靶向内皮细胞中神经纤毛蛋白 1 依赖性 ABL1 激活来抑制 VEGF 非依赖性血管生成。

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.

机构信息

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, England UK

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, England UK.

出版信息

J Exp Med. 2014 Jun 2;211(6):1167-83. doi: 10.1084/jem.20132330. Epub 2014 May 26.

DOI:10.1084/jem.20132330
PMID:24863063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4042645/
Abstract

To enable new blood vessel growth, endothelial cells (ECs) express neuropilin 1 (NRP1), and NRP1 associates with the receptor tyrosine kinase VEGFR2 after binding the vascular endothelial growth factor A (VEGF) to enhance arteriogenesis. We report that NRP1 contributes to angiogenesis through a novel mechanism. In human and mouse ECs, the integrin ligand fibronectin (FN) stimulated actin remodeling and phosphorylation of the focal adhesion component paxillin (PXN) in a VEGF/VEGFR2-independent but NRP1-dependent manner. NRP1 formed a complex with ABL1 that was responsible for FN-dependent PXN activation and actin remodeling. This complex promoted EC motility in vitro and during angiogenesis on FN substrates in vivo. Accordingly, both physiological and pathological angiogenesis in the retina were inhibited by treatment with Imatinib, a small molecule inhibitor of ABL1 which is widely used to prevent the proliferation of tumor cells that express BCR-ABL fusion proteins. The finding that NRP1 regulates angiogenesis in a VEGF- and VEGFR2-independent fashion via ABL1 suggests that ABL1 inhibition provides a novel opportunity for anti-angiogenic therapy to complement VEGF or VEGFR2 blockade in eye disease or solid tumor growth.

摘要

为了促进新血管的生长,内皮细胞(ECs)会表达神经纤毛蛋白 1(NRP1),并且在与血管内皮生长因子 A(VEGF)结合后,NRP1 与受体酪氨酸激酶 VEGFR2 结合,以增强动脉生成。我们报告 NRP1 通过一种新的机制促进血管生成。在人源和鼠源 ECs 中,整合素配体纤维连接蛋白(FN)在 VEGF/VEGFR2 非依赖性但 NRP1 依赖性的方式下刺激肌动蛋白重塑和粘着斑组件整联蛋白连接激酶(PXN)的磷酸化。NRP1 与 ABL1 形成复合物,该复合物负责 FN 依赖性 PXN 激活和肌动蛋白重塑。该复合物促进了细胞体外迁移,以及在体内 FN 底物上的血管生成过程中的迁移。因此,视网膜中的生理性和病理性血管生成均被 ABL1 的小分子抑制剂伊马替尼抑制,伊马替尼广泛用于预防表达 BCR-ABL 融合蛋白的肿瘤细胞的增殖。这一发现表明,NRP1 通过 ABL1 以 VEGF 和 VEGFR2 非依赖性的方式调节血管生成,这提示 ABL1 抑制为抗血管生成治疗提供了一个新的机会,可与眼部疾病或实体瘤生长中 VEGFR2 或 VEGF 的阻断相补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/f5ab73c5a908/JEM_20132330R_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/0b75c09292e8/JEM_20132330_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/a07ab58b48f1/JEM_20132330_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/e40a7304bfcd/JEM_20132330_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/fd213bc4203c/JEM_20132330_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/0a1b302774d4/JEM_20132330R_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/dd808a985aaa/JEM_20132330_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/807f1fe5d174/JEM_20132330R_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/f5ab73c5a908/JEM_20132330R_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/0b75c09292e8/JEM_20132330_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/a07ab58b48f1/JEM_20132330_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/e40a7304bfcd/JEM_20132330_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/fd213bc4203c/JEM_20132330_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/0a1b302774d4/JEM_20132330R_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/dd808a985aaa/JEM_20132330_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/807f1fe5d174/JEM_20132330R_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fcf/4042645/f5ab73c5a908/JEM_20132330R_Fig8.jpg

相似文献

1
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.伊马替尼通过靶向内皮细胞中神经纤毛蛋白 1 依赖性 ABL1 激活来抑制 VEGF 非依赖性血管生成。
J Exp Med. 2014 Jun 2;211(6):1167-83. doi: 10.1084/jem.20132330. Epub 2014 May 26.
2
VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.VEGF(血管内皮生长因子)通过 ADAMs(解整合素和金属蛋白酶)9 和 10 诱导 NRP1(神经纤毛蛋白-1)裂解,生成新的羧基末端 NRP1 片段,调节血管生成信号。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1845-1858. doi: 10.1161/ATVBAHA.118.311118.
3
VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.VEGF 与 NRP1 的结合对于 VEGF 刺激内皮细胞迁移、NRP1 与 VEGFR2 之间的复合物形成以及通过 FAK Tyr407 磷酸化进行信号转导至关重要。
Mol Biol Cell. 2011 Aug 1;22(15):2766-76. doi: 10.1091/mbc.E09-12-1061. Epub 2011 Jun 8.
4
The BCR::ABL1 tyrosine kinase inhibitors ponatinib and nilotinib differentially affect endothelial angiogenesis and signalling.BCR::ABL1酪氨酸激酶抑制剂波纳替尼和尼洛替尼对内皮血管生成和信号传导有不同影响。
Mol Cell Biochem. 2025 Mar;480(3):1627-1643. doi: 10.1007/s11010-024-05070-5. Epub 2024 Jul 15.
5
c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1.c-ABL 通过直接磷酸化衔接蛋白 GRB2 和 NCK1 来调节 VEGFR-2 信号下游的 MAP 激酶激活。
Angiogenesis. 2012 Jun;15(2):187-97. doi: 10.1007/s10456-012-9252-6. Epub 2012 Feb 11.
6
Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.神经纤毛蛋白-1通过ABL1增强细胞外基质信号传导以促进血管生成。
Biochem Soc Trans. 2014 Oct;42(5):1429-34. doi: 10.1042/BST20140141.
7
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells.神经纤毛蛋白-1/GIPC1信号通路调节内皮细胞中α5β1整合素的转运和功能。
PLoS Biol. 2009 Jan 27;7(1):e25. doi: 10.1371/journal.pbio.1000025.
8
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.神经纤毛蛋白-1在调节血管内皮生长因子诱导的p38丝裂原活化蛋白激酶激活及内皮细胞组织形成中的作用
Blood. 2008 Nov 1;112(9):3638-49. doi: 10.1182/blood-2007-12-125856. Epub 2008 Jul 29.
9
Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.低分子量岩藻依聚糖通过增强VEGF165与VEGFR-2和神经纤毛蛋白1(NRP1)的结合来增加VEGF165诱导的内皮细胞迁移。
J Biol Chem. 2006 Dec 8;281(49):37844-52. doi: 10.1074/jbc.M600686200. Epub 2006 Oct 6.
10
Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.神经纤毛蛋白 1(NRP1)功能降低与 VEGF-A 结合缺陷联合揭示了 NRP1 在发育和病理性血管生成中的新作用。
Development. 2014 Feb;141(3):556-62. doi: 10.1242/dev.103028. Epub 2014 Jan 8.

引用本文的文献

1
Understanding Merkel Cell Carcinoma: Pathogenic Signaling, Extracellular Matrix Dynamics, and Novel Treatment Approaches.了解默克尔细胞癌:致病信号传导、细胞外基质动态变化及新的治疗方法。
Cancers (Basel). 2025 Apr 2;17(7):1212. doi: 10.3390/cancers17071212.
2
The lactylation modification of proteins plays a critical role in tumor progression.蛋白质的乳酸化修饰在肿瘤进展中起关键作用。
Front Oncol. 2025 Mar 19;15:1530567. doi: 10.3389/fonc.2025.1530567. eCollection 2025.
3
Crosstalk between GLTSCR1-deficient endothelial cells and tumour cells promotes colorectal cancer development by activating the Notch pathway.

本文引用的文献

1
Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.神经纤毛蛋白 1(NRP1)功能降低与 VEGF-A 结合缺陷联合揭示了 NRP1 在发育和病理性血管生成中的新作用。
Development. 2014 Feb;141(3):556-62. doi: 10.1242/dev.103028. Epub 2014 Jan 8.
2
Filopodia are dispensable for endothelial tip cell guidance.丝状伪足对于血管内皮细胞前体细胞的导向作用可有可无。
Development. 2013 Oct;140(19):4031-40. doi: 10.1242/dev.097352.
3
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
GLTSCR1缺陷的内皮细胞与肿瘤细胞之间的串扰通过激活Notch信号通路促进结直肠癌的发展。
Cell Death Differ. 2025 Jan 27. doi: 10.1038/s41418-025-01450-6.
4
Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions.神经纤毛蛋白-1通过旁分泌调节内皮细胞黏附连接来控制血管通透性。
Angiogenesis. 2024 Dec 12;28(1):7. doi: 10.1007/s10456-024-09963-3.
5
Reassessment of arterial versus venous perfusion of diabetic retinal neovascularization using ultrawide-field fluorescein angiography.使用超广角荧光素血管造影术重新评估糖尿病视网膜新生血管形成的动脉灌注与静脉灌注情况。
Graefes Arch Clin Exp Ophthalmol. 2025 Feb;263(2):361-368. doi: 10.1007/s00417-024-06650-3. Epub 2024 Oct 8.
6
Three cases of uncommon medication-associated osteonecrosis of temporal bone.三例罕见的药物相关性颞骨骨坏死病例。
World J Otorhinolaryngol Head Neck Surg. 2023 Dec 3;10(3):237-240. doi: 10.1002/wjo2.146. eCollection 2024 Sep.
7
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis.早期间歇性高脂血症会使组织巨噬细胞发生改变,从而促进动脉粥样硬化的发生。
Nature. 2024 Oct;634(8033):457-465. doi: 10.1038/s41586-024-07993-x. Epub 2024 Sep 4.
8
A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis.内皮细胞中由 H3K9 乳糖化和 HDAC2 驱动的反馈环调节 VEGF 诱导的血管生成。
Genome Biol. 2024 Jun 25;25(1):165. doi: 10.1186/s13059-024-03308-5.
9
Differential modulation of cell morphology, migration, and Neuropilin-1 expression in cancer and non-cancer cell lines by substrate stiffness.基质硬度对癌细胞系和非癌细胞系中细胞形态、迁移及神经纤毛蛋白-1表达的差异调节
Front Cell Dev Biol. 2024 Jun 5;12:1352233. doi: 10.3389/fcell.2024.1352233. eCollection 2024.
10
Development of a cancer metastasis-on-chip assay for high throughput drug screening.用于高通量药物筛选的癌症芯片转移检测方法的开发。
Front Oncol. 2024 Jan 4;13:1269376. doi: 10.3389/fonc.2023.1269376. eCollection 2023.
癌症中血管生成和抗血管生成治疗的最新分子发现。
J Clin Invest. 2013 Aug;123(8):3190-200. doi: 10.1172/JCI70212. Epub 2013 Aug 1.
4
Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival. Abl 激酶对于血管功能、Tie2 表达和血管生成素-1 介导的生存是必需的。
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12432-7. doi: 10.1073/pnas.1304188110. Epub 2013 Jul 9.
5
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.神经纤毛蛋白 1 的胞质结构域是 VEGF-A 依赖性血管生成所必需的。
Dev Cell. 2013 Apr 29;25(2):156-68. doi: 10.1016/j.devcel.2013.03.019.
6
VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma.VEGF-A 对于实验性青光眼模型中的视网膜神经保护是必需且充分的。
Am J Pathol. 2013 Apr;182(4):1379-90. doi: 10.1016/j.ajpath.2012.12.032. Epub 2013 Feb 12.
7
Ocular neovascularization.眼部新生血管。
J Mol Med (Berl). 2013 Mar;91(3):311-21. doi: 10.1007/s00109-013-0993-5. Epub 2013 Jan 18.
8
Neuropilin signalling in vessels, neurons and tumours.神经纤毛蛋白信号在血管、神经元和肿瘤中的作用。
Semin Cell Dev Biol. 2013 Mar;24(3):172-8. doi: 10.1016/j.semcdb.2013.01.001. Epub 2013 Jan 11.
9
NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis.NRP1 在血管生成过程中自主作用于内皮细胞,促进尖端细胞的功能。
Blood. 2013 Mar 21;121(12):2352-62. doi: 10.1182/blood-2012-05-424713. Epub 2013 Jan 11.
10
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.肿瘤分泌的 miR-9 通过激活 JAK-STAT 通路促进内皮细胞迁移和血管生成。
EMBO J. 2012 Aug 29;31(17):3513-23. doi: 10.1038/emboj.2012.183. Epub 2012 Jul 6.